Log in

NASDAQ:DSCI - Derma Sciences Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume719,592 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Derma Sciences, Inc (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Supplies
SectorN/A
Current SymbolNASDAQ:DSCI
CUSIP24982750
Phone+1-609-5144744

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive DSCI News and Ratings via Email

Sign-up to receive the latest news and ratings for DSCI and its competitors with MarketBeat's FREE daily newsletter.


Derma Sciences (NASDAQ:DSCI) Frequently Asked Questions

What is Derma Sciences' stock symbol?

Derma Sciences trades on the NASDAQ under the ticker symbol "DSCI."

How were Derma Sciences' earnings last quarter?

Derma Sciences Inc (NASDAQ:DSCI) posted its quarterly earnings data on Tuesday, August, 9th. The medical instruments supplier reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.16. The medical instruments supplier earned $22.20 million during the quarter, compared to analysts' expectations of $22.40 million. View Derma Sciences' Earnings History.

Has Derma Sciences been receiving favorable news coverage?

Media stories about DSCI stock have trended negative this week, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Derma Sciences earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the company's share price in the next several days. View News Stories for Derma Sciences.

Who are some of Derma Sciences' key competitors?

What other stocks do shareholders of Derma Sciences own?

What is Derma Sciences' official website?

The official website for Derma Sciences is http://www.dermasciences.com/.

How can I contact Derma Sciences?

Derma Sciences' mailing address is 214 Carnegie Ctr Ste 300, PRINCETON, NJ 08540-6237, United States. The medical instruments supplier can be reached via phone at +1-609-5144744.


MarketBeat Community Rating for Derma Sciences (NASDAQ DSCI)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  235 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  403
MarketBeat's community ratings are surveys of what our community members think about Derma Sciences and other stocks. Vote "Outperform" if you believe DSCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: What is a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel